AbbVie Inc to participate at the UBS Global Health Care Conference
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and...
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and...
Sanofi announced that it has filed for premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the...
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the...
• Detects biomarkers of horse infection, inflammation, immune response and general health • Addresses unmet needs of equine research...
fizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved...
Pfizer Inc announced patient enrollment completion in the global SPIRE-2 cardiovascular outcome trial for its investigational agent bococizumab. SPIRE-2 is...
Merck and Pfizer announced the treatment of the first patient in a Phase III study of avelumab*, an investigational fully...
AstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical...
Sun Pharma announced that one of its wholly owned subsidiaries has received approval from USFDA for its New Drug Application...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.